BioCentury
ARTICLE | Financial News

Amgen slides on 1Q14 miss

April 24, 2014 12:33 AM UTC

Amgen Inc. (NASDAQ:AMGN) fell $5.99 to $113.32 on Wednesday after reporting 1Q14 earnings late Tuesday that missed the Street. Adjusted diluted EPS was $1.87 on revenues of $4.5 billion. The Street wa...